CIRSE 2025: SAVE trial reports higher efficacy for Selution SLR DEB in failing AVF
A first report from the SAVE prospective, multicentre, single-blinded randomised controlled trial of the Selution sustained limus release (SLR; Cordis) drug-eluting balloon (DEB) in...
SUCCESS PTA stratified analysis finds equal benefit for sirolimus DEB above and below the...
Positive 12-month outcomes for the Selution Sustained Limus Release (SLR; Cordis) drug-eluting balloon (DEB) were observed, with consistent haemodynamic, functional and clinical improvements irrespective...
Cook Medical and Siemens Healthineers announce strategic commercial partnership
Cook Medical and Siemens Healthineers announce a strategic commercial partnership aimed at setting a new standard for interventional medicine.
In a recent press release the...
Sirtex receives expanded CE mark approval for SIR-Spheres Y90 resin microspheres
Sirtex Medical today announced that it has received an expanded CE mark approval for SIR-Spheres yttrium 90 (Y90) resin microspheres for the treatment of...
